Journal Flyer

Current Issue 2018  Archive 2017 
Biography
Biography

Editor-in-Chief of OBM Hepatology and Gastroenterology

Osamu Yokosuka is an Emeritus Professor of Chiba University, Japan. He graduated from Chiba University School of Medicine in 1975 then worked as a trainee under Professor K. Okuda in Chiba University Hospital till 1978. Dr. Yokosuka was a research fellow worked under Professor S. Scherlock and Professor B. H. Billing in Royal Free Hospital, London, UK from 1978 to 1980; under Professor M. Omata in Chiba University from 1980 to 1985; and under Dr. J Summers in Fox Chase Cancer Center, PA, USA in 1984. In 1985, he received a Degree of Doctor of Medical Science, and served as an Assistant Professor in Chiba University till 1994, then as Lecturer in Medicine till 2006 when he was appointed as Director and Professor of Medicine. From 2013 to 2015, he served as the Dean of Chiba University School of Medicine.

Dr. Yokosuka was the Secretary General of APASL (2008-2014). In 2016, he was elected as the President of APASL Tokyo, the President of 52nd Annual Meeting of Japan Society of Hepatology, and the President of Funabashi Central Hospital. Dr. Yokosuka’s research mainly focuses on Hepatitis and Hepatocellular Carcinoma. So far, he has published more than 700 original papers.

Biography

The Associate Editor of OBM Hepatology and Gastroenterology

Tatsuo Kanda received a medical degree in 1991 at Niigata University School of Medicine, Japan, and his PhD in 1999 at Chiba University Graduate School of Medicine, Japan. He had post-doctor training for 3 years under Prof. Ratna Ray and Prof. Ranjit Ray at Saint Louis University, St. Louis, MO, USA. In Dec. 2008, Tatsuo Kanda became a Tenure-track Associate Professor at Department of Medicine and Clinical Oncology, Chiba University, Graduate School of Medicine, Japan. In Feb. 2013, Tatsuo Kanda was nominated a permanent Associate Professor at Department of Gastroenterology and Nephrology, Chiba University, Graduate School of Medicine, Japan. In 2017, Tatsuo Kanda became an Associate Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nihon University School of Medicine. For ~25 years, he has focused his scientific interests on the topics related to liver diseases including acute liver failure, viral hepatitis and autoimmune liver diseases, and worked with Prof. Osamu Yokosuka. Tatsuo Kanda is also an expert for hepatitis A virus (HAV), HBV and HCV, and translation and replication of these viruses, and hepatocarcinogenesis. With his expertise in antiviral therapies and hepatitis virus research, Tatsuo Kanda also sees a lot of patients in clinical daily practice. Tatsuo Kanda has published more than 200 articles in peer-reviewed Journal.

Special Issue

Next Generation Sequencing

Submission Deadline: August 31, 2017 (Open)               Submit Now

Guest Editors

Ute Moog, MD, PhD
Professor, Institute of Human Genetics, Heidelberg University, 69120 Heidelberg, Germany
E-Mail: [email protected]
Website: https://www.klinikum.uni-heidelberg.de/Patientenversorgung.100281.0.html
Research Interests: genetics; pediatrics; dysmorphology; intellectual disability; neurocutaneous disorders

Domenico Coviello, MD, PhD
Director of Laboratory of Human Genetics, Department of Genetic Sciences and I.B.M.D.R., Galliera Hospital, Via Volta 6, 16128 Genova, Italy
E-Mail: [email protected]
Website: http://galliera.it/
Research Interests: genetics; cytogenetics; prenatal diagnosis; human biology

About This Topic

Next Generation Sequencing (NGS) was introduced as a new high-throughput sequencing technology about 10 years ago and since then has proven to be a landmark in genetics. Enabling large genomic parts or even the whole genome to be sequenced at costs dropped to an amazingly low level, NGS has quickly become a powerful research tool, and has allowed the identification of numerous disease genes. It has continued to evolve as a clinical tool and is now being used as panel diagnostics for heterogeneous disorders or exome sequencing. Thus, NGS has considerably contributed to what is called reverse genetics, i.e. the delineation of a phenotype after identification of the genotype, and has greatly changed the profile of the genetic profession.

In this special issue of OBM Genetics, we aim to highlight NGS experiences from more than a decade. The issue not only addresses the state of art of guidelines that have been established and the overwhelming advancements in different medical fields made by NGS but also sheds light on the many challenges and limitations this method faces, and discusses ethical issues as well as the influence it has on training policies.

Substantial comments/contributions to any aspect of NGS are welcome and we invite young scientists (under 40) to send their most recent publication on their effort/activity in the development/application of this technology or any professional who are involved in the consequence of this application with patients or at population level. We will give two awards of 500 Euros each to a young scientist for the attendance to a meeting, one to the best contribution on technology/application aspect and one for the best contribution on ELSI (Ethical, Legal, psycho-Social Issues). Information on this will be announced on the website of the Journal.

Planned Papers

Title: Integration of Genomic Diagnostics into Clinical Practice
Authors: Sarah Bowdin 1; Ian Krantz 2
Affiliations: 1. Centre for Genetic Medicine, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Ontario, Canada;
2. Division of Human Genetics and the Roberts Individualized medical genetics Center at the Children’s Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania

Publication

Editorial

Introduction to the Special Issue on Next Generation Sequencing: Short General Overview of NGS

Ute Moog, Domenico Coviello
Received: August 14, 2018; Published: September 17, 2018; doi:10.21926/obm.genet.1802034

Opinion

German Guidelines for Molecular Genetic Diagnostic Testing Using High-throughput Technology, Such As Next-Generation Sequencing

Peter Bauer, Gabriele Wildhardt, Dieter Gläser, Clemens Müller-Reible, Hanno J. Bolz, Hanns-Georg Klein, Ulrich Finckh, Ute Hehr
Received: September 24, 2017; Published: April 28, 2018; doi:10.21926/obm.genet.1802019

Research Article

Identification and Prioritization of Causal Variants of Human Genetic Disorders from Exome or Whole Genome Sequencing Data

Nagarajan Paramasivam, Martin Granzow, Christina Evers, Katrin Hinderhofer, Stefan Wiemann, Claus R. Bartram, Roland Eils, Matthias Schlesner
Received: October 24, 2017; Published: April 16, 2018; doi:10.21926/obm.genet.1802017

Research Article

Application of Clinical Next Generation Sequencing in Intensive Care Facilitates Rapid Diagnosis of Neonates with Rare Genetic Disorders

Tobias Geis, Ute Hehr, Roland Brandl, Saskia Herbst, Hugo Segerer, Michael Melter, Sophie Hinreiner
Received: August 31, 2017; Published: March 6, 2018; doi:10.21926/obm.genet.1801015

Review

Next Generation Sequencing in Autism Spectrum Disorder

Jiani Yin, David Oleson, Christian P. Schaaf
Received: August 31, 2017; Published: February 24, 2018; doi:10.21926/obm.genet.1801014

Research Article

Next Generation Sequencing and Pediatric Brain Tumors: Detection of Cancer Predisposition Syndromes in Patients and Their Families

Kerstin Grund, Dominik Sturm, Christian Sutter, Felix Sahm, Katrin Hinderhofer, Christian Kratz, Daniel Schrimpf, Andreas von Deimling, Kristian W. Pajtler, David TW Jones, Stefan M. Pfister, Nicola Dikow
Received: September 1, 2017; Published: December 6, 2017; doi:10.21926/obm.genet.1704011